Shree Ganesh Remedies is currently trading at Rs. 73.50, down by 1.00 points or 1.34% from its previous closing of Rs. 74.50 on the BSE.
The scrip opened at Rs. 73.50 and has touched a high and low of Rs. 73.50 and Rs. 73.50 respectively. So far 1500 shares were traded on the counter.
The BSE group 'M' stock of face value Rs. 10 has touched a 52 week high of Rs. 88.70 on 15-Nov-2019 and a 52 week low of Rs. 50.50 on 18-Feb-2019.
Last one week high and low of the scrip stood at Rs. 74.50 and Rs. 71.50 respectively. The current market cap of the company is Rs. 66.84 crore.
The promoters holding in the company stood at 62.72% and Non-Institutions hold 37.28%.
Shree Ganesh Remedies has achieved success in developing a new aromatic fine chemical product and has also received a trial export order worth $220,000 from its International Client. The company is expecting more export orders in coming financial year.
Shree Ganesh Remedies is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry. The company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, alzheimers and anti-viral.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |